Metrics as of 10/17/2026, 02:41 AM (Berlin time), refresh in progress.
Tekla Life Sciences Investors Stock
Tekla Life Sciences Investors
Company data
- Sector
- Financial Services
- Industry
- Asset Management
- Country
- United States
- CEO
- Daniel R. Omstead
- Market cap
- $510 M
- IPO
- 01/05/1992
Tekla Life Sciences Investors, a closed-ended equity mutual fund, is expertly managed by Tekla Capital Management LLC. This U.S.-domiciled fund, which commenced operations on February 20, 1992, and was formerly known as H&Q Life Sciences Investors, seeks investment opportunities in publicly traded companies worldwide.…
Tekla Life Sciences Investors stock: price history
1D
-2.7%
1W
-7.5%
1M
-13.0%
6M
-6.8%
YTD
+0.0%
1Y
+1.2%
2Y
+11.1%
5Y
-18.8%
10Y
-2.7%
Next earnings date
Next earnings date
No date known
Volatility around earnings
~19% stronger price swings than usual
Tekla Life Sciences Investors stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 24/09/2026.
Ask the agents about Tekla Life Sciences Investors
Tekla Life Sciences Investors stock metrics
P/E
2.49
P/B
0.91
EV/EBITDA
2.57
RETURN ON EQUITY
11.7%
NET MARGIN
135.9%
DEBT/EQUITY
0
DIVIDEND YIELD
13.3%
AS OF
31/03/2026
Free float & liquidity
FREE FLOAT
90.2%
FLOAT SHARES
27,435,101
AVG. DAILY VOLUME (30D)
128,152
Insider transactions (SEC)
Mahai Chris LaVictoire
Institutional holders
Dividends
Comparable stocks
Frequently asked questions about Tekla Life Sciences Investors stock
What does Tekla Life Sciences Investors do?
Tekla Life Sciences Investors is a company in the Financial Services sector, Asset Management industry, headquartered in United States.
The IPO was on 01/05/1992; the stock trades on NYSE under the ticker HQL.
When does Tekla Life Sciences Investors report next?
Around past earnings, price swings were roughly 19% stronger than usual.
Does Tekla Life Sciences Investors pay a dividend?
Yes. The last dividend was US$0.62 per share, ex-date 24/08/2026, paid on 30/09/2026.
The dividend yield is 13.3% (as of 31/03/2026).
Which stocks are comparable to Tekla Life Sciences Investors?
Comparable stocks include BlackRock, Blackstone, KKR &, Apollo Global Management, State Street, Ameriprise Financial, Ares Management and Northern Trust.
How can I get Tekla Life Sciences Investors stock analyzed?
Clicking "Analyze stock" lets five strategies assess Tekla Life Sciences Investors against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.